![David Jin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Jin
Direttore Finanziario/CFO presso
AVENUE THERAPEUTICS, INC.
Patrimonio netto: 60 590 $ in data 31/05/2026
Profilo
David Jin is currently Independent Director at Mustang Bio, Inc. since 2024.
Holds director position at Crystalys Therapeutics, Inc. Serves as Treasurer at Urica Therapeutics, Inc., Cyprium Therapeutics, Inc., Cellvation, Inc., and Helocyte, Inc. since 2022.
Acts as Secretary, Chief Operating & Financial Officer at Avenue Therapeutics, Inc. since 2022.
Functions as CFO & Head-Corporate Development at Fortress Biotech, Inc. since 2020.
Formerly Director at Barings LLC from 2017 to 2020.
Served as Director-Corporate Development at Sorrento Therapeutics, Inc. from 2016 to 2017.
Was Vice President-Healthcare Investment Banking at FBR & Co. from 2013 to 2016.
Completed undergraduate education at Northwestern University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 22/06/2026 | 21.571 ( 0,06% ) | 60 399 $ | 31/05/2026 | |
| 30/12/2025 | 286 ( 0% ) | 192 $ | 31/05/2026 | |
| 25/11/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di David Jin
| Società | Posizione | Inizio |
|---|---|---|
| AVENUE THERAPEUTICS, INC. | Direttore Finanziario/CFO | 11/05/2022 |
| FORTRESS BIOTECH, INC. | Direttore Finanziario/CFO | 16/08/2022 |
| MUSTANG BIO, INC. | Direttore/Membro del Consiglio | 23/10/2024 |
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for the treatment of menkes disease and related copper metabolism disorders | Treasurer | 01/08/2022 |
Urica Therapeutics, Inc. | Treasurer | 01/08/2022 |
Helocyte, Inc.
 Helocyte, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops novel immunotherapies for the prevention and treatment of cancer and infectious disease | Treasurer | 01/08/2022 |
Cellvation, Inc.
 Cellvation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cellular therapeutics for treatment of traumatic brain injury | Treasurer | 01/08/2022 |
Precedenti posizioni note di David Jin
| Società | Posizione | Fine |
|---|---|---|
Barings LLC
 Barings LLC Investment ManagersFinance Barings? investment decisions across all asset classes incorporate a comprehensive analysis that uses or combines top-down and/or bottom-up approaches to investment analysis. The firm utilizes economic, fundamental, technical/cyclical, and quantitative analyses, along with a sound understanding of both macro drivers and micro considerations in its investment decision-making process and to manage risk. They invest in a variety of fixed income and financing instruments across various industries as well as credit qualities and maturities in North America, Europe, Latin America, Africa/Middle East, and the Asia-Pacific region. Barings manages portfolios of public equity securities and equity-related securities of issuers of all sizes. The firm has teams focused on three alternative investment sectors: Real Estate, Private Equity & Real Assets, and Funds & Co-Investments. | Direttore/Membro del Consiglio | 01/05/2020 |
| SORRENTO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/07/2017 |
| ░░░ ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di David Jin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
44
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Barings LLC
Barings LLC Investment ManagersFinance Barings? investment decisions across all asset classes incorporate a comprehensive analysis that uses or combines top-down and/or bottom-up approaches to investment analysis. The firm utilizes economic, fundamental, technical/cyclical, and quantitative analyses, along with a sound understanding of both macro drivers and micro considerations in its investment decision-making process and to manage risk. They invest in a variety of fixed income and financing instruments across various industries as well as credit qualities and maturities in North America, Europe, Latin America, Africa/Middle East, and the Asia-Pacific region. Barings manages portfolios of public equity securities and equity-related securities of issuers of all sizes. The firm has teams focused on three alternative investment sectors: Real Estate, Private Equity & Real Assets, and Funds & Co-Investments. | Finance |
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FBR & Co.
 FBR & Co. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Avenue Therapeutics, Inc.
 Avenue Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and commercializes therapies for neurological diseases | Health Technology |
Helocyte, Inc.
Helocyte, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops novel immunotherapies for the prevention and treatment of cancer and infectious disease | Health Technology |
Mustang Bio, Inc.
 Mustang Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops novel immunotherapy''s | Health Technology |
Cyprium Therapeutics, Inc.
Cyprium Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for the treatment of menkes disease and related copper metabolism disorders | Health Technology |
Cellvation, Inc.
Cellvation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cellular therapeutics for treatment of traumatic brain injury | Health Technology |
Urica Therapeutics, Inc. |
